Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
GSK PLC Sponsored ADR (GSK) had Free Cash Flow of $4.45B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$11.29B |
|
$583.81M |
|
$3.04B |
|
$8.24B |
|
$10.64B |
|
$645.55M |
|
$-170.45M |
|
$475.10M |
|
$479.13M |
|
$742.18M |
|
$742.18M |
|
$742.18M |
|
$743.94M |
|
$645.55M |
|
$3.72B |
|
2.01B |
|
2.03B |
|
$0.29 |
|
$0.29 |
|
| Balance Sheet Financials | |
$23.57B |
|
$12.56B |
|
$59.29B |
|
$82.86B |
|
$28.90B |
|
$18.72B |
|
$30.90B |
|
$59.81B |
|
$23.05B |
|
$-9.40B |
|
$23.05B |
|
-- |
|
| Cash Flow Statement Financials | |
$5.14B |
|
$-3.03B |
|
$-2.52B |
|
$4.36B |
|
$3.95B |
|
$-410.68M |
|
-- |
|
$-1.84B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
0.45 |
|
1.06 |
|
73.05% |
|
5.72% |
|
5.72% |
|
-- |
|
4.21% |
|
5.17% |
|
|
Free Cash Flow |
$4.45B |
-- |
|
-- |
|
-- |
|
0.14 |
|
0.36 |
|
1.04 |
|
86.41 |
|
3.22% |
|
-7.89% |
|
0.90% |
|
1.78% |
|
-- |
|
$2.19 |
|
$2.53 |
|